降钙素基因相关肽 Calcitonin gene-related peptide (CGRP) is a fascinating neuropeptide that plays a significant role in various physiological processes, most notably as a potent vasodilator. This 37-amino acid peptide, produced by the calcitonin gene, is widely distributed throughout both the central and peripheral nervous systemsCalcitonin Gene Related Peptide (CGRP) II, human. While CGRP is intrinsically linked to the pain of migraine attacks due to its role in causing inflammation in the brain's coverings, its functions extend far beyond this, impacting areas such as intestinal motility, inflammation, and even modulating the autonomic nervous system. Understanding CGRP's complex actions is crucial, especially as it has become a target for new therapeutic strategies, particularly in migraine treatmentThe Role of Calcitonin Gene Related Peptide (CGRP) in ....
CGRP's influence spans multiple bodily systems, highlighting its importance in maintaining homeostasis. As a potent vasodilator, it plays a critical role in regulating blood flow. Beyond this primary function, CGRP is involved in a range of other processes, including:
* Inflammation: CGRP can trigger inflammatory responses, which is a key factor in the pathophysiology of migraine headaches.
* Intestinal Motility: It influences the movement of food through the digestive tract.
* Apoptosis: CGRP has been implicated in programmed cell death.
* Autonomic Nervous System Modulation: It interacts with and influences the sympathetic and parasympathetic nervous systems, affecting functions like heart rate and blood pressure.When CGRP is released, it causesintense inflammation in the coverings of the brain(the meninges), and for most migraine patients, causes the pain of a ...
* Appetite and Digestion: CGRP is involved in appetite suppression and the release of gastric acid.Calcitonin Gene Related Peptide II (CGRP II, human), cyclic
* Temperature Homeostasis: It contributes to the regulation of body temperature.
The connection between calcitonin gene-related peptide and migraine is a primary focus of research and clinical interest.calcitonin-gene-related-peptide CGRP is released during migraine attacks and is believed to contribute significantly to the throbbing pain experienced by sufferersCalcitonin Gene-Related Peptide Receptor Agonism. This release can cause intense inflammation in the meninges, the protective membranes surrounding the braincalcitonin-gene-related-peptide. This understanding has paved the way for the development of novel migraine treatments.
The prominent role of CGRP in migraine has led to the development of specific therapeutic agents. These include:
* CGRP Receptor Antagonists (Gepants): These drugs block the action of CGRP at its receptor, offering a new approach to both the acute treatment and prevention of migraines. Gepants are a class of oral medications that have shown significant promise for migraine patientsRoles of calcitonin gene-related peptide in the skin, and other ....
* CGRP Monoclonal Antibodies: These injectable therapies target CGRP itself or its receptor. By binding to CGRP or its receptor, they effectively neutralize its activity, thereby reducing the frequency and severity of migraine attacks. These antibodies are metabolized into peptides and amino acids, which can reduce the risk of drug-drug interactions and hepatotoxicity.作者：J Ailani·2022·被引用次数：61—Calcitonin gene-related peptide (CGRP) is involved in several of the pathophysiologic processes underpinning migraine attacks.
Calcitonin gene-related peptide exists in different forms, with alpha-CGRP (α-CGRP) and beta-CGRP (β-CGRP) being the two main isoforms. These are produced through the tissue-specific processing of the calcitonin gene. The effects of CGRP are mediated through its specific receptor, the Calcitonin Gene-Related Peptide Receptor (CGRPR). Research into the CGRP system, including its various forms and receptor interactions, continues to uncover new insights into its physiological roles and therapeutic potential.
While significant strides have been made in understanding and treating conditions like migraine by targeting CGRP, research is ongoing. Scientists are exploring CGRP's involvement in other conditions and seeking to further elucidate its complex systemic effects.CGRP Inhibitors: What They Are, Uses & Side Effects - Cleveland Clinic The ongoing investigation into CGRP and its receptor system promises to yield further advancements in medicine and a deeper comprehension of human physiology.
Join the newsletter to receive news, updates, new products and freebies in your inbox.